Abstract
For many years, a pathological immune response has been implicated in the development of chronic pancreatitis. However, only in the last decade autoimmune pancreatitis (AIP) has been recognized as a distinct entity with typical histopathological and immunological findings. AIP is frequently associated with other autoimmune diseases, such as Sjogrens syndrome, sclerosing extra-hepatic cholangitis and retroperitoneal fibrosis. Although AIP is rare, improved diagnostics is of significant clinical interest because of the prompt response to steroid treatment. In this review, we describe the characteristic features of AIP and focus on the molecular pathogenesis of the disease.
Keywords: Autoimmune pancreatitis, molecular pathogenesis
Current Pharmaceutical Design
Title: Molecular Characteristics of Autoimmune Pancreatitis
Volume: 12 Issue: 29
Author(s): Robert Jaster and Jorg Emmrich
Affiliation:
- ,0
Keywords: Autoimmune pancreatitis, molecular pathogenesis
Abstract: For many years, a pathological immune response has been implicated in the development of chronic pancreatitis. However, only in the last decade autoimmune pancreatitis (AIP) has been recognized as a distinct entity with typical histopathological and immunological findings. AIP is frequently associated with other autoimmune diseases, such as Sjogrens syndrome, sclerosing extra-hepatic cholangitis and retroperitoneal fibrosis. Although AIP is rare, improved diagnostics is of significant clinical interest because of the prompt response to steroid treatment. In this review, we describe the characteristic features of AIP and focus on the molecular pathogenesis of the disease.
Export Options
About this article
Cite this article as:
Jaster Robert and Emmrich Jorg, Molecular Characteristics of Autoimmune Pancreatitis, Current Pharmaceutical Design 2006; 12(29) . https://dx.doi.org/10.2174/138161206778559812
| DOI https://dx.doi.org/10.2174/138161206778559812 |
Print ISSN 1381-6128 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Allegations from Whistleblowers
- Publishing Ethics
- Increase Visibility Of Your Article
- Self Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Endothelial Effects of Drugs Designed to Treat Erectile Dysfunction
Current Pharmaceutical Design The Expanding Role of TNF-Receptor Super Family Member CD40 (tnfrsf5) in Autoimmune Disease: Focus on Th40 Cells
Current Immunology Reviews (Discontinued) Blood Brain Barrier Compromise with Endothelial Inflammation may Lead to Autoimmune Loss of Myelin during Multiple Sclerosis
Current Neurovascular Research The Use of Citrullinated Peptides for the Diagnosis and Prognosis of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters Gluten-dependent Intestinal Autoimmune Response
Current Pharmaceutical Design Models of Antigen Receptor Activation in the Design of Vaccines
Current Pharmaceutical Design Autoantibody-Induced Formation of Immune Complexes in Normal Human Serum
Current Pharmaceutical Design Current and Potential Agents for the Treatment of Alopecia Areata
Current Pharmaceutical Design Naturally Arising CD25+CD4+ Regulatory T Cells in Maintaining Immunologic Self-Tolerance and Preventing Autoimmune Disease
Current Molecular Medicine Monoclonal Antibodies: A Review
Current Clinical Pharmacology Current and Future Therapeutic Targets of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug
Current Topics in Medicinal Chemistry Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design Regulation of the Immune Response by Natural IgM: Lessons from Warm Autoimmune Hemolytic Anemia
Current Pharmaceutical Design Design, Synthesis and In Vitro Release Studies of Co-Drugs for Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Tec Family Kinases in Inflammatory Processes
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Dietary N-3 Fatty Acids and Calorie Restriction in Autoimmune Disease:Influence in Different Immune Compartments
Current Organic Chemistry The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) The Role of STATs in Inflammation and Inflammatory Diseases
Current Pharmaceutical Design




